DailyDoctor Archive Specialties Get app
All obstetrics & gynaecology briefings

The edition · Obstetrics & Gynaecology

Antibiotics after second-degree tears cut the odds of wound complications by about two-thirds

A Danish trial cohort names who needs closer perineal follow-up; untreated subclinical hypothyroidism mostly corrects itself; and cervicovaginal Ureaplasma tracks with preterm birth without justifying screening.

The edition in brief

Five items for obstetricians and gynaecologists. In 433 Danish women with second-degree tears or episiotomy from the REPAIR trial, 12.7% had a clinically relevant wound complication; prophylactic amoxicillin-clavulanate was associated with lower odds (aOR 0.34, 0.18 to 0.65), while a prolonged active second stage (aOR 2.25) and a deep tear (aOR 2.11) raised them. In the placebo arms of two NICHD trials, 88.7% of women with subclinical hypothyroidism and 61.4% with hypothyroxinaemia had a normal thyroid test later in pregnancy, and only 2.0 to 2.5% became overtly hypothyroid, a caution against reflex early treatment. A meta-analysis of 156 observational studies associated cervicovaginal Ureaplasma parvum with preterm birth (OR 1.63) and Mycoplasma hominis with preterm birth (aOR 1.75) and low birthweight, but the authors state this does not support routine screening or treatment. A prospective study of 14,114 pregnant women found 1.7% were HPA-1b/1b; 2 of 19 higher-risk women followed up alloimmunised by 10 weeks post partum. The pearl covers what to check at the perineal review for women at higher risk of breakdown.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for obstetrics & gynaecology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free